Press monitoring
Engineered fat cells slip through blood-brain barrier to illuminate early-stage tumors
21.12.2015 | Press monitoring
Cancerous growths that arise from the supportive tissue of the brain, known as gliomas, account for around 30 percent of all brain tumors and carry an average survival rate of just 14 months. These aggressive tumors are difficult to detect through MRI, largely due to the the protective blood-brain barrier that stops contrast agents from...
Gene-editing is Science mags breakthrough of 2015
18.12.2015 | Press monitoring
A gene-editing technique known as CRISPR was named Thursday by the influential US journal Science as 2015's breakthrough of the year, due to its potential to revolutionize health and medicine. The method has stirred controversy, particularly after Chinese researchers earlier this year announced they had deliberately edited the DNA of nonviable...
A metabolic pathway in cyanobacteria could yield better bioproducts
16.12.2015 | Press monitoring
Scientists from the Energy Department's National Renewable Energy Laboratory (NREL) have discovered that a metabolic pathway previously only suggested to be functional in photosynthetic organisms is actually a major pathway and can enable efficient conversion of carbon dioxide to organic compounds. The discovery shines new light on the complex...
Medtronic Announces New High-Tech Facility in Galway; Building on Global Synergies
14.12.2015 | Press monitoring
DUBLIN- December 14, 2015 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, today announced a new manufacturing facility in Galway, Ireland that will manufacture the market-leading IN.PACT® Admiral® drug-coated balloon (DCB) for the treatment of peripheral artery disease (PAD). PAD is a build-up of plaque...
Navamedic expands market reach for Sippi
14.12.2015 | Press monitoring
Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, has secured distribution of its new Sippi urine measurement system in the Benelux markets. Navamedic has signed an agreement with Ecomed Services bvba of Belgium, a distributor of infection control and intensive care products.
Photocure: Visonac® data published in the British Journal of Dermatology
14.12.2015 | Press monitoring
Oslo, Norway, December 14 , 2015: Photocure (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces the publication of the results from the Phase 2b trial of Visonac (methyl aminolevulinate 80mg/g), a novel topical acne treatment, in the British Journal of Dermatolo...
The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back
14.12.2015 | Press monitoring
DUBLIN - December 14, 2015 - Medtronic (NYSE: MDT) announced today that 12 people representing 11 countries will be honored with the 2015 Bakken Invitation Award, which recognizes people who have overcome health challenges with the help of medical technology and are making outstanding contributions of service, volunteerism and le...
Novavax, Inc: Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
14.12.2015 | Press monitoring
GAITHERSBURG, Md., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced complete target enrollment of the pivotal Phase 3 clinical trial, known as Resolve(TM), of its respiratory...
Periodic Table of Protein Complexes presented
14.12.2015 | Press monitoring
The Periodic Table of Protein Complexes, published today in Science, offers a new way of looking at the enormous variety of structures that proteins can build in nature, which ones might be discovered next, and predicting how entirely novel structures could be engineered. Created by an interdisciplinary team led by researchers at the Wellcome...
Medtronic Announces FDA Approval of Infuse® Bone Graft for Three New Spine Surgery Indications
11.12.2015 | Press monitoring
DUBLIN - December 11, 2015 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of additional spine surgery indications for Infuse® Bone Graft. Upon receiving final labeling approval from the FDA, the company expects to begin marketing these expanded indications in early calendar year 2016. With this...
